Halozyme Therapeutics, listed on Nasdaq, received a buy rating from TD Cowen, which was disclosed to the SEC.

The entities involved

• Halozyme Therapeutics →

  Nothing else this week.

• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12
• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28

Related events

• HCW Biologics Inc. filed disclosures with the SEC and its shares are listed on Nasdaq.Jun 27
• Repay Holdings Corporation disclosed a transaction in an SEC filing and trades on Nasdaq.Sep 22
• Keurig Dr Pepper is trading on the Nasdaq stock exchange and filing required reports with the SEC.Jul 6
• Pro-Dex, Inc. was listed on the Nasdaq stock exchange and disclosed a transaction via a legal filing with the SEC.Sep 13
• Dropbox disclosed market activity to the SEC and its stock traded on the Nasdaq exchange.Sep 10